Association between MIF gene variation and Meniere's disease.

Area of Science:

• Immunogenetics
• Otolaryngology
• Molecular Medicine

Background:

• Menière's disease (MD) is a disorder with suspected immune system involvement.
• Macrophage migration inhibitory factor (MIF) is crucial in immune reactions and its gene polymorphisms are linked to autoimmune diseases.
• The role of MIF gene polymorphisms in Menière's disease susceptibility requires further investigation.

Purpose of the Study:

• To investigate the association between the MIF-173 G/C gene polymorphism and Menière's disease in an Iranian population.
• To determine if MIF gene variations contribute to the risk or pathogenesis of Menière's disease.

Main Methods:

• A case-control study design was employed.
• Genotyping of the MIF-173 G/C polymorphism was performed using the PCR-RFLP technique.
• MD patients (N=72) and healthy controls (N=100) were analyzed.

Main Results:

• A significant increase in the GG genotype of the MIF-173 G/C polymorphism was observed in Menière's disease patients compared to controls (P=0.02).
• This association was more pronounced in definitive Menière's disease cases (P=0.009).
• The odds ratio for MD associated with the GG genotype was 2.08 (95% CI: 1.02-4.3) and 2.6 (95% CI: 1.19-6.18) for definitive MD.

Conclusions:

• The MIF-173 G/C polymorphism is potentially associated with Menière's disease in the studied population.
• The findings suggest a role for MIF in the pathogenesis of Menière's disease, particularly in its definitive form.
• Further research is warranted to elucidate the specific pathogenic mechanisms and diagnostic potential of this genetic marker.